Family Office · Mt Waverley, VIC, Australia
D4 Bioventures is a venture capital firm focused on investing in early-stage biotechnology and life sciences companies. The firm specializes in supporting startups that are developing innovative therapeutics and technologies in areas such as drug discovery, diagnostics, and healthcare solutions. D4 Bioventures is known for its hands-on approach, providing both capital and strategic guidance to portfolio companies. The firm is headquartered in the United States and is recognized for its involvement in advancing cutting-edge biomedical research and fostering the growth of emerging biotech enterprises.
Business models
deeptech_ip, platform, services
Customer segments
Medical Research Institutes, Universities, Early-stage Startups, Established Biotech Companies
Geography
Australia, APAC
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
D4 Bioventures deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VC Boom tracks D4 Bioventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Advent Life Sciences Llp
biotech_therapeutics, deeptech_ip, hardware
Seed VC
Aktiebolag Grenspecialisten
software, diagnostics, life science
Seed VC
AMR Action Fund
biotech, antimicrobial resistance, antibiotics
Angel
Angel Academe - increasing female investment
cleantech, healthtech, fintech
Family Office
Artichoke Capital
blockchain, fintech, AI
Family Office
Bioworld Ventures
biopharma, medtech, orthopedics
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. D4 Bioventures is one of them, and we'll tell you exactly where they sit in your top 100.